Aadil Zaman, Partner at Wall Street Alliance Group discusses inflationary pressure on wages, and the pending U.S. infrastructure package. Dr. David Giljohann, CEO of Exicure discusses a new class of therapeutics used to treat diseases and the power of new technologies to develop treatments faster and cheaper. Kristina Hooper, Chief Global Market Strategist at Invesco, discusses the health of the U.S. economy, soaring housing prices, and wage growth. George Goldsmith, CEO of Compass Pathways discusses the mental health landscape and the integration of clinically driven psychedelic therapies.